Viemed Healthcare (VMD) president reports new RSUs and phantom units

Rhea-AI Filing Summary

Viemed Healthcare President Michael Moore reported equity compensation and related share settlements. On January 19, 2026, he received 118,759 Restricted Stock Units and 29,690 phantom share units, each representing the value of one common share and vesting in three equal annual installments beginning on the first anniversary of the grant date. Earlier, on January 17, 2026, previously granted RSUs and phantom units vested, resulting in the acquisition and disposition of matching common shares, including 8,548 shares withheld at $7.33 per share to cover taxes. After these transactions, Moore directly beneficially owned 144,734 common shares and indirectly owned 1,722,614 common shares through Moore Faster LLC.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Moore Michael

(Last) (First) (Middle)

625 E. KALISTE SALOOM RD.

(Street)

LAFAYETTE LA 70508

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
VIEMED HEALTHCARE, INC. [ VMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President

3. Date of Earliest Transaction (Month/Day/Year)
01/17/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	01/17/2026		M		26,939	A	(1)	153,282	D
Common Shares	01/17/2026		F		8,548(2)	D	$7.33(3)	144,734	D
Common Shares	01/17/2026		M		6,735	A	(4)	151,469	D
Common Shares	01/17/2026		D		6,735	D	$7.33(3)	144,734	D
Common Shares								1,722,614	I	by Moore Faster LLC

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	01/17/2026		M			26,939	(5)	01/17/2026	Common Shares	26,939	$0	0	D
Phantom Share Units	(4)	01/17/2026		M			6,735	(6)	01/17/2026	Common Shares	6,735	(4)	0	D
Restricted Stock Units	(1)	01/19/2026		A		118,759		(7)	01/19/2029	Common Shares	118,759	$0	118,759	D
Phantom Share Units	(8)	01/19/2026		A		29,690		(9)	01/19/2029	Common Shares	29,690	$0	29,690	D

Explanation of Responses:

1. Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.

2. Shares that were withheld by the issuer to satisfy the reporting person's tax obligation resulting from the vesting of restricted stock units.

3. Per share value is based on the market closing price of the common shares for January 16, 2026.

4. Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash.

5. Restricted Stock Units (RSUs) granted to reporting person on January 17, 2023, which vest in three equal annual installments beginning on the first anniversary of the grant date.

6. Represents an award granted on January 17, 2023 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date.

7. Restricted Stock Units (RSUs) granted to reporting person on January 19, 2026, which vest in three equal annual installments beginning on the first anniversary of the grant date.

8. Each phantom share represents a right to receive the cash value of one share of the Issuer's common shares which will be determined based on the Issuer's share price on the vesting date.

9. Represents an award granted on January 19, 2026 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date.

Remarks:

	/s/ Jesse Bergeron, Attorney-in-Fact	01/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did Viemed Healthcare (VMD) report for Michael Moore?

The filing shows that President Michael Moore had RSUs and phantom share units vest on January 17, 2026, settled into common shares with some shares withheld for taxes and some disposed of, and received new equity awards on January 19, 2026.

How many Restricted Stock Units were granted to Michael Moore on January 19, 2026?

On January 19, 2026, Michael Moore was granted 118,759 Restricted Stock Units, each representing a contingent right to receive one Viemed common share, vesting in three equal annual installments beginning on the first anniversary of the grant date.

What phantom share units did Michael Moore receive from Viemed Healthcare (VMD)?

On January 19, 2026, Michael Moore received 29,690 phantom share units under Viemed’s Phantom Share Unit Plan, each tied to the cash value of one common share determined on the vesting date and vesting in three equal annual installments.

Why were some Viemed Healthcare shares withheld in Michael Moore’s Form 4?

The Form 4 notes that 8,548 common shares were withheld by Viemed to satisfy Michael Moore’s tax obligations arising from the vesting of restricted stock units. The per-share value used was $7.33, based on the January 16, 2026 closing price.

How many Viemed Healthcare common shares does Michael Moore own after these transactions?

After the reported transactions, Michael Moore beneficially owned 144,734 common shares directly and 1,722,614 common shares indirectly through Moore Faster LLC.

What is the role of Michael Moore at Viemed Healthcare (VMD)?

Michael Moore is an officer of Viemed Healthcare, serving as the company’s President, as indicated in the filing.